Shenlan Mao
Impact in
-
- Monoclonal and Polyclonal Antibodies Research
- Oncology top 10%
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
Papers in
-
- Monoclonal and Polyclonal Antibodies Research 25
- Oncology 11
- HER2/EGFR in Cancer Research 11
- Co-authors
- Changshou GaoKim D. JandaPeter WirschingRichard A. LernerChih‐Hung L. LoHerren WuJay HarperRyan Fleming
- Journals
- Proceedings of the National Academy of Sciences (5 papers)Bioconjugate Chemistry (3 papers)Journal of the American Chemical Society (2 papers)Journal of Pharmaceutical Sciences (1 paper)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesGermanySouth Korea
In The Last Decade
Shenlan Mao
32 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 75
- Radiology, Nuclear Medicine and Imaging 646
- Oncology 380
- Molecular Biology 813
- Cellular and Molecular Neuroscience 150
- Immunology and Allergy 44
Countries citing papers authored by Shenlan Mao
This map shows the geographic impact of Shenlan Mao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shenlan Mao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shenlan Mao more than expected).
Fields of papers citing papers by Shenlan Mao
This network shows the impact of papers produced by Shenlan Mao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shenlan Mao. The network helps show where Shenlan Mao may publish in the future.
Co-authors
The 25 scholars most cited alongside Shenlan Mao, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 10 | |
| 2 | 2019 | 28 | |
| 3 | 2019 | 21 | |
| 4 | 2019 | 2 | |
| 5 | 2019 | 6 | |
| 6 | 2018 | 85 | |
| 7 | 2018 | 2 | |
| 8 | 2018 | 60 | |
| 9 | 2016 | 28 | |
| 10 | 2015 | 102 | |
| 11 | 2015 | 24 | |
| 12 | 2013 | 29 | |
| 13 | 2010 | 57 | |
| 14 | 2009 | 63 | |
| 15 | 2004 | 30 | |
| 16 | 2003 | 35 | |
| 17 | 2002 | 74 | |
| 18 | 2001 | 31 | |
| 19 | 1999 | 111 | |
| 20 | 1999 | 14 |
About Shenlan Mao
Shenlan Mao is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology, Molecular Biology, Immunology and Allergy and Organic Chemistry, having authored 32 papers that have together received 1.2k indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (25 papers), Glycosylation and Glycoproteins Research (12 papers), HER2/EGFR in Cancer Research (11 papers), Chemical Synthesis and Analysis (8 papers), Click Chemistry and Applications (5 papers), Axon Guidance and Neuronal Signaling (3 papers), Angiogenesis and VEGF in Cancer (3 papers) and Synthesis and pharmacology of benzodiazepine derivatives (2 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (646 citations), Oncology (380 citations), Molecular Biology (813 citations), Cellular and Molecular Neuroscience (150 citations) and Immunology and Allergy (44 citations). Shenlan Mao has collaborated with scholars based in United States, Germany and South Korea. Frequent co-authors include Changshou Gao, Kim D. Janda, Peter Wirsching, Richard A. Lerner, Chih‐Hung L. Lo, Herren Wu, Jay Harper, Ryan Fleming, R. James Christie and Gunnar F. Kaufmann. Their work appears in journals such as Proceedings of the National Academy of Sciences, Bioconjugate Chemistry, Journal of the American Chemical Society, Journal of Pharmaceutical Sciences and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.